The varied attractions of the diabetic foot

British Journal of Diabetes and Vascular Disease

Volumn 9, Issue 4, 2009, Pages 155-159

  Leese, Graham P ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Amputation; Diabetes; Foot; Neuropathy; Screening; Ulcer

Indexed keywords

AMITRIPTYLINE; AMOXICILLIN PLUS CLAVULANIC ACID; CAPSAICIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; DULOXETINE; FLUCLOXACILLIN; GABAPENTIN; METRONIDAZOLE; OXYCODONE; PARACETAMOL; PREGABALIN; RIFAMPICIN; VENLAFAXINE;

ACUPUNCTURE; ANGIOPLASTY; CLOSTRIDIUM DIFFICILE; DEBRIDEMENT; DIABETIC FOOT; DIABETIC NEUROPATHY; FOOT AMPUTATION; FOOT ULCER; HIGH RISK PATIENT; HUMAN; HYDROTHERAPY; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEUROPATHIC PAIN; ORTHOSIS; OSTEOMYELITIS; PERIPHERAL VASCULAR DISEASE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SCREENING; SHOE; UNSPECIFIED SIDE EFFECT; VACUUM ASSISTED CLOSURE; WOUND HEALING; WOUND INFECTION;

EID: 73449102514     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651409341420     Document Type: Review

References (54)

1. Edmonds ME, Blundell MP, Morris ME et al. Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med 1986;60:763-771
2. Larsson J, Apelqvist J, Agardh CD, Stenström A. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet Med 1995;12:770-776
3. Oyibo SO, Jude EB, Tarawneh I et al. A comparison of two diabetic foot ulcer classification systems. Diabetes Care 2001;24:84-88
4. Pound N, Chipchase S, Treece K, et al. Ulcer free survival following management of foot ulcers in diabetes. Diabet Med 2005;22:1306-1309
5. Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 2006;29:1784-1787
6. Leese GP, Schofield CJ, McMurray B, et al. Scottish foot ulcer risk score predicts healing in a regional specialist foot clinic. Diabetes Care 2007;30:2064-2069
7. Armstrong DG, Nguyen HC, Lavery LA, et al. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001; 24:1019-1022
8. Katz IA, Harlan A, Miranda-Palma B, et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005;28:555-559
9. Blume PA, Walters J, Payne W, et al. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 2008;31:631-636
10. Gregor S, Maegele M, Sauerland S, et al. Negative pressure wound therapy. Arch Surg 2008;143:189-196
11. Braakenburg A, Obdeijn MC, Feitz R, et al. The efficacy and cost effectiveness of the vacuum-assisted closure technique in the management of chronic wounds: a randomized controlled trial. Plast Reconstr Surg 2006;118:390-400.
12. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998;21:855-859
13. Ince P, Abbas ZG, Lutale JK, et al. Use of the SINBAD classification system and score in comparing outcome of foot ulcer management on three continents. Diabetes Care 2008;31:964-967
14. Lavery LA, Armstrong DG, Murdoch DP et al. Validation of the infectious diseases society of america's diabetic foot infection classification system. Clin Infect Dis 2007;44:562-565
15. Berendt AR, Peters EJ, Bakker K, et al. Specific guidelines for treatment of diabetic foot osteomyelitis. Diabetes Metab Res Rev 2008; 24(Suppl 1):S190-1.
16. Berendt AR, Peters EJ, Bakker K, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 2008;24(Suppl 1):S145-61.
17. Lipsky BA. New developments in diagnosing and treating diabetic foot infections. Diab Met Res Rev 2008;28(Suppl 1):S66-71.
18. Leese G, Nathwani D, Young M, et al. Use of antibiotics in people with diabetic foot disease: A consensus statement. Diab Foot 2009;12:62-78.
19. Shone A, Burnside J, Chipchase S, et al. Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes. Diabetes Care 2006;29:945.
20. Lavery LA, Armstrong DG, Peters EJ, Lipsky BA. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes Care 2007;30:270-274
21. Game FL, Jeffcoate WJ. Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia 2008;51:962-967
22. Game FL, Catlow R, Jeffcoate WJ et al. CDUK: a UK-wide, web-based survey of the management of the acute Charcot foot of diabetes. Diabetic foot complications. Diabet Med 2009;26(suppl 1):P282.
23. Petrova NL, Foster AV, Edmonds ME. Difference in presentation of charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care 2004;27:1235-1236
24. Stuck RM, Sohn MW, Budiman-Mak E, et al. Charcot arthropathy risk elevation in the obese diabetic population. Am J Med 2008; 121:1008-1014
25. Lavery LA, Peters EJ, Armstrong DG. What are the most effective interventions in preventing diabetic foot ulcers? Int Wound J 2008;5:425-433
26. Abbott CA, Carrington AL, Ashe H et al. The North West Diabetes Care Foot study: incidence of, risk factors for, new diabetic foot ulceration in a community-based cohort. Diab Med 2002;19:377-384
27. Tesfaye S, Chaturvedi N, Eaton SE, et al. EURODIAB Prospective Complications Study Group Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341-350
28. Hurley RW, Lesley MR, Adams MC, et al. Pregabalin as a treatment for painful diabetic peripheral neuropathy: a meta-analysis. Reg Anesth Pain Med 2008;33:389-394
29. Wernicke JF, Pritchett YL, D'Souza DN et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006;67:1411-1420
30. Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol 2008;1:29
31. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004;110:697-706.
32. Watson CP, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:71-78
33. Winell K, Niemi M, Lepantalo M. The national hospital discharge register data on lower limb amputations. Eur J Vasc Endovasc Surg 2006;32:66-70.
34. Adam DJ, Beard JD, Cleveland T, et al. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-1934
35. Harrison S, Cochrane L, Abboud R, Leese GP. Do patients with diabetes wear the correct sized shoes for their feet? Int J Clin Pract 2007; 61:1900-1904
36. Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995;18:1376-1378
37. Stanway SE RS, Gill GV, Kaczmarcyk E, Kaye L. Diabetic holiday foot syndrome: a preventable complication. Pract Diabetes Int 2001;18:45-47.
38. Boyko EJ, Ahoroni JH, Cohen V, et al. Prediction of diabetic foot ulcer occurrence using commonly available clinical information. Diabetes Care 2006;29:1202-1207
39. Boyko EJ, Ahoroni JH, Stensel V et al. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999;22:1036-1042
40. International Working Group on the Diabetic Foot. Five cornerstones. Identification of the foot at risk. IWGDF 2009. www.iwgdf.org/index.php?option= com-content&task=view&id=39&Itemid=60 (accessed 26 June 2009).
41. Scottish Intercollegiate Guideline Network (SIGN). SIGN guideline 55: The management of Diabetes. Royal College of Physicians Edinburgh: SIGN (2001). www.sign.ac.uk/guidelines/index.html (accessed 14th June 2009).
42. Peters EJ, Lavery LA. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2001;24:1442-1447
43. Leese GP, Reid F, Green V, et al. Predicting foot ulceration in Diabetes: validation of a clinical tool in a population-based study. Int J Clin Pract 2006;60:541-545
44. Trautner C, Haastert B, Mauckner P, et al. Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990-2005: results of the Leverkusen Amputation Reduction Study (LARS). Diabetes Care 2007;30:2633-2637
45. Krishnan S, Nash F, Baker N, et al. Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care 2008;31:99-101.
46. Holstein P, Ellitsgaard N, Olsen BB, Ellitsgaard V. Decreasing incidence of major amputations in people with diabetes. Diabetologia 2000;43:844-847
47. Van Houtum WH, Rauwerda JA, Ruwaard D, et al. Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000. Diabetes Care 2004;27:1042-1046
48. Canavan RJ, Unwin NC, Kelly WF, Connolly VM. Diabetes- and nondiabetes-related lower extremity amputation incidence before and after the introduction of better organized diabetes foot care: continuous longitudinal monitoring using a standard method. Diabetes Care 2008;31:459-463
49. Schofield CJ, Yu N, Jain AS, Leese GP. Decreasing amputation rates in patients with diabetes: a population based study. Diabet Med 2009 (in press).
50. Scottish Diabetes Survey (2007). www.diabetesinscotland.org.uk/ Publications/Scottish%20Diabetes%20Survey%202007.PDF (accessed 3 February 2009).
51. Young MJ, McCardle JE, Randall LE, Barclay JI. Improved survival of diabetic foot ulcer patients 1995-2008, possible impact of aggressive cardiovascular risk management. Diabetes Care 2008;31:2143-2147
52. Schofield CJ, Libby G, Brennan GM, et al. Mortality and hospitalisation in patients after amputation: a comparison between patients with and without diabetes. Diabetes Care 2006;29:2252-2256
53. Aulivola B, Hile CN, Hamdan AD, et al. Major lower extremity amputation: outcome of a modern series. Arch Surg 2004;139:395-399
54. Tentolouris N, Al-Sabbagh S, Walker MG, et al. Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study. Diabetes Care 2004;27:1598-1604